Related Experiment Video
Updated: Aug 17, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced
1Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas, TX 77030, USA.
Abstract:
DiFi human colon carcinoma cells are stimulated by the transforming growth factor-alpha (TGF-alpha)/epidermal growth factor (EGF) receptor autocrine loop. Exposure of DiFi cells to monoclonal antibody (mAb) 225, which blocks ligand-induced activation of the EGF receptor, induces G1 arrest and subsequent cell death via apoptosis. We investigated the signal pathways by which basic fibroblast growth factor (bFGF) and insulin-like growth factor-1 (IGF-1) modulate mAb 225-induced G1 arrest and apoptosis in DiFi cells. Both bFGF and IGF-1 activated the mitogen-activated protein kinase (MAPK) kinase (MEK) pathway in DiFi cells. Additionally, IGF-1 activated the phosphoinositide 3-kinase (PI-3K)/Akt pathway. Both bFGF and IGF-1 inhibited mAb 225-induced apoptosis; however, bFGF provided sustained protection against apoptosis, while the protection by IGF-1 was only temporary. Also, bFGF reversed the mAb 225-induced increase in the p27(Kip1) level, inhibition of cyclin-dependent kinase-2 (CDK-2) activity, dephosphorylation of the retinoblastoma (Rb) protein and the resultant G1 arrest of the cells. In contrast, IGF-1 did not reverse such effects by mAb 225. The prevention of mAb 225-induced G1 arrest and apoptosis in DiFi cells by bFGF was sensitive to the MEK/MAPK inhibitor PD98059 but not to the PI-3K inhibitor LY294002. In contrast, inhibition of apoptosis by IGF-1 in DiFi cells was sensitive only to LY294002 and not to PD98059. These results further our understanding of how mAb 225 induces apoptosis in DiFi cells.
Insights
Basic fibroblast growth factor (bFGF) and insulin-like growth factor-1 (IGF-1) differentially regulate apoptosis in colon cancer cells. bFGF sustained protection via the MAPK pathway, while IGF-1 offered temporary protection through PI-3K/Akt.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- DiFi human colon carcinoma cells utilize a transforming growth factor-alpha (TGF-alpha)/epidermal growth factor (EGF) receptor autocrine loop.
- Monoclonal antibody (mAb) 225 blocks EGF receptor activation, inducing G1 arrest and apoptosis in DiFi cells.
Purpose of the Study:
- Investigate how basic fibroblast growth factor (bFGF) and insulin-like growth factor-1 (IGF-1) influence mAb 225-induced G1 arrest and apoptosis.
- Elucidate the specific signaling pathways modulated by bFGF and IGF-1 in this context.
Main Methods:
- Treatment of DiFi cells with mAb 225, bFGF, and IGF-1.
- Assessment of cell cycle arrest (G1), apoptosis, and activation of signaling pathways (MAPK, PI-3K/Akt).
- Utilized pathway-specific inhibitors (PD98059 for MEK/MAPK, LY294002 for PI-3K).
Main Results:
- Both bFGF and IGF-1 activated the MEK/MAPK pathway; IGF-1 also activated PI-3K/Akt.
- Both growth factors inhibited mAb 225-induced apoptosis, with bFGF providing sustained protection and IGF-1 temporary protection.
- bFGF reversed mAb 225-induced G1 arrest markers (p27 Kip1, CDK-2 activity, Rb dephosphorylation), while IGF-1 did not.
- bFGF's protective effects were MEK/MAPK-dependent, whereas IGF-1's were PI-3K-dependent.
Conclusions:
- bFGF and IGF-1 differentially modulate apoptosis and cell cycle arrest induced by EGF receptor blockade in colon cancer cells.
- The MEK/MAPK pathway mediates bFGF's sustained anti-apoptotic and cell cycle-regulating effects.
- The PI-3K/Akt pathway mediates IGF-1's temporary anti-apoptotic effects.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
TGF - β Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal